CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company
BIOMERICA INC
Sign in to watch- Ticker
- BMRA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 952645573
- Phone
- 9493792875
- Business address
- 17571 VON KARMAN AVENUE, IRVINE, CA, 92614
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 10-K/A Report 10-K/A
- S-3 Offering Registration Statement
- S-3 Offering Registration Statement
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 10-K Report Annual Report
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 31,250 shares at $1.60 ($50,000)
- 4 Open-market buy Director bought 10,000 shares at $1.60 ($16,000)
- 4 Open-market buy Director bought 6,250 shares at $1.60 ($10,000)
- 4 Open-market buy Executive Vice Chairman bought 20,000 shares at $1.60 ($32,000)
- 4 Open-market buy Chief Executive Officer bought 31,250 shares at $1.60 ($50,000)
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
Page 1 of 31 · 605 filings